6[6]D' Agostino G,Distefano M,Greggi S,et al.Neo-adjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin,paclitaxel and cisplatin.Cancer Chemother Pharmacol,2002,49:256-260.
7[7]Park DC,Kim JH,Lew YO,et al.Phase Ⅱ trial of neoadjuvant paclitaxel and cisplatin in uterine cervical cancer.Gynecol Oncol,2004,92:59-63.
8[8]Zanetta G,Fei F,Mangioni C.Chemotherapy with paclitaxel,ifosfamide,and cisplatin for the treatment of squamous cell cervical cancer:the experience of Monza.Semin Oncol,2000,27 (Suppl 1):23-27.
9[9]Zanetta G,Lissoni A,Pellegrino A,et al.Neoadjuvant chemotherapy with cisplatin,ifosfamide and paclitaxel for locally advanced squamouscell cervical cancer.Ann Oncol,1998,9:977.
10[10]Zanetta G,Mangioni C,Fei F,et al.A multicenter randomized trial on neoadjuvant chemotherapy with paclitaxel,ifosfamide and cisplatin (TIP)vs IP followed by surgery for locally advanced squamous cell cervical cancer (SCC).Proceedings of the Eighth Meeting of the International Gynecological Cancer Society,2000.A236.
3Mcneil C. New standard of care for cervical cancer sets next questions. JClin Oncol , 1999 , 91 : 500 -- 501.
4Nishio S, Ota S, Sugiyama T, Weekly 1- h paclitaxel infusion in pa- tients with recurrent endometrial cancer: a preliminary study. Int J Clin Oncol. 20033 8(1): 45--8.
5Green JA , Kirwan JM. Survival and recurrence after concomitant che2 motherapy and radiotherapy for cancer of the uterine cervix : a system2 atlc review and meta analysis[J ] . Lancet ,2001 , 358 (9284):781.
6Chen MD , Paley PJ , Potish RA , et al. Phase I Trial of Taxol as a Ra- diation Sensitizer with Cisplatin in Advanced Cervical Cancer. Gynecol Oncol , 1997 , 67 : 131 -- 136.
7Pignata S , Frezza P , Tramontana S , et al. Phase I study with weekly cisplatin--paclitaxel and concurrent radiotherapy in patients with carci- noma of the cervix uteri [J ] . Ann Oncol ,2000 ,11 (4) :455--459.
8Rao GG, Rogers P , Drake RD , et al . Phase I clinical trial of weekly paclitaxel , weekly carboplatin , and concurrent radiotherapy for prima- rycervical cancer. Gynecol Oncol , 2005 , 96 : 168 -- 172.
